title: Neural tissue engineering: Bioresponsive nanoscaffolds using engineered self-assembling peptides.
abstract: Rescuing or repairing neural tissues is of utmost importance to the patient's quality of life after an injury. To remedy this, many novel biomaterials are being developed that are, ideally, non-invasive and directly facilitate neural wound healing. As such, this review surveys the recent approaches and applications of self-assembling peptides and peptide amphiphiles, for building multi-faceted nanoscaffolds for direct application to neural injury. Specifically, methods enabling cellular interactions with the nanoscaffold and controlling the release of bioactive molecules from the nanoscaffold for the express purpose of directing endogenous cells in damaged or diseased neural tissues is presented. An extensive overview of recently derived self-assembling peptide-based materials and their use as neural nanoscaffolds is presented. In addition, an overview of potential bioactive peptides and ligands that could be used to direct behaviour of endogenous cells are categorized with their biological effects. Finally, a number of neurotrophic and anti-inflammatory drugs are described and discussed. Smaller therapeutic molecules are emphasized, as they are thought to be able to have less potential effect on the overall peptide self-assembly mechanism. Options for potential nanoscaffolds and drug delivery systems are suggested.
  
  
  
  Self-assembling nanoscaffolds have many inherent properties making them amenable to tissue engineering applications: ease of synthesis, ease of customization with bioactive moieties, and amenable for in situ nanoscaffold formation. The combination of the existing knowledge on bioactive motifs for neural engineering and the self-assembling propensity of peptides is discussed in specific reference to neural tissue engineering.
authors.affiliation: Department of Chemical and Materials Engineering, University of Alberta, 9211 - 116 Street NW, Edmonton, AB, Canada T6G 1H9; National Institute for Nanotechnology, 11421 Saskatchewan Dr NW, Edmonton, AB, Canada T6G 2M9.
authors.forename: K M
authors.initials: KM
authors.lastname: Koss
authors.affiliation: Department of Chemical and Materials Engineering, University of Alberta, 9211 - 116 Street NW, Edmonton, AB, Canada T6G 1H9; National Institute for Nanotechnology, 11421 Saskatchewan Dr NW, Edmonton, AB, Canada T6G 2M9. Electronic address: lunswort@ualberta.ca.
authors.forename: L D
authors.initials: LD
authors.lastname: Unsworth
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D001672:Biocompatible Materials / Q000494:pharmacology*; D016503:Drug Delivery Systems; D006801:Humans; D053758:Nanoparticles / Q000737:chemistry*; D009417:Nerve Tissue / Q000187:drug effects / Q000502:physiology*; D010455:Peptides / Q000737:chemistry / Q000494:pharmacology*; D023822:Tissue Engineering / Q000379:methods*; D054457:Tissue Scaffolds / Q000737:chemistry*
chemical_list: D001672:Biocompatible Materials; D010455:Peptides
keywords: Drug delivery; Engineered peptides; Nanoscaffold; Neural tissue engineering; Self-assembly